GLAUKOS Corp (GKOS) Current Ratio
- Current ratio · latest quarter: Value 5.04×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 5.04× | Current assets / current liabilities. $515.78M ÷ $102.33M ≈ 5.04× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 515.78M USD | Assets, Current |
| Current obligations | 102.33M USD | Liabilities, Current |
| Cash and equivalents | 114.48M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 138.90M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 59.31M USD | Inventory, Net |
| Payables | 19.14M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $515.78M | $102.33M | $114.48M | (m) | $138.90M | $59.31M | $19.14M | (m) | 5.04× |
| 2026-03-31 | $485.75M | $89.42M | $104.25M | (m) | $119.69M | $62.38M | $19.15M | (m) | 5.43× |
| 2025-12-31 | $474.98M | $101.28M | $90.81M | (m) | $108.61M | $63.56M | $24.62M | (m) | 4.69× |
| 2025-09-30 | $454.77M | $87.52M | $98.25M | (m) | $98.68M | $63.86M | $19.88M | (m) | 5.20× |
| 2025-06-30 | $436.06M | $79.14M | $100.81M | (m) | $82.98M | $64.62M | $13.68M | (m) | 5.51× |
| 2025-03-31 | $444.54M | $68.53M | $114.25M | (m) | $71.53M | $59.46M | $15.82M | (m) | 6.49× |
| 2024-12-31 | $449.79M | $75.13M | $169.63M | (m) | $60.74M | $57.68M | $13.03M | (m) | 5.99× |
| 2024-09-30 | $397.28M | $71.68M | $100.14M | (m) | $56.41M | $59.90M | $11.10M | (m) | 5.54× |
| 2024-06-30 | $383.78M | $70.08M | $68.08M | (m) | $51.22M | $56.48M | $11.56M | (m) | 5.48× |
| 2024-03-31 | $388.61M | $72.24M | $42.49M | (m) | $46.55M | $50.19M | $12.75M | (m) | 5.38× |
| 2023-12-31 | $395.46M | $74.01M | $93.47M | (m) | $39.85M | $41.99M | $13.44M | (m) | 5.34× |
| 2023-09-30 | $399.53M | $67.15M | $108.93M | (m) | $39.33M | $39.78M | $10.41M | (m) | 5.95× |
| 2023-06-30 | $401.26M | $63.89M | $94.81M | (m) | $39.25M | $39.45M | $8.56M | (m) | 6.28× |
| 2023-03-31 | $415.88M | $62.39M | $76.40M | (m) | $37.85M | $40.45M | $12.03M | (m) | 6.67× |
| 2022-12-31 | $443.86M | $72.36M | $119.53M | (m) | $36.07M | $37.84M | $14.40M | (m) | 6.13× |
| 2022-09-30 | $448.84M | $60.62M | $104.02M | (m) | $34.77M | $34.18M | $11.46M | (m) | 7.40× |
| 2022-06-30 | $471.10M | $69.51M | $102.55M | (m) | $36.03M | $27.84M | $21.29M | (m) | 6.78× |
| 2022-03-31 | $491.20M | $55.60M | $106.20M | (m) | $34.80M | $24.71M | $8.00M | (m) | 8.84× |
| 2021-12-31 | $486.13M | $63.36M | $100.71M | (m) | $33.44M | $23.01M | $7.33M | (m) | 7.67× |
| 2021-09-30 | $501.81M | $63.45M | $113.13M | (m) | $35.24M | $19.72M | $8.46M | (m) | 7.91× |
| 2021-06-30 | $490.54M | $349.48M | $118.30M | (m) | $37.57M | $17.50M | $6.96M | (m) | 1.40× |
| 2021-03-31 | $474.30M | $335.56M | $96.63M | (m) | $36.69M | $15.27M | $8.62M | (m) | 1.41× |
| 2020-12-31 | $469.44M | $49.70M | $96.60M | (m) | $36.06M | $15.81M | $4.37M | (m) | 9.45× |
| 2020-09-30 | $454.44M | $46.69M | $80.99M | (m) | $32.88M | $19.89M | $6.77M | (m) | 9.73× |
| 2020-06-30 | $453.22M | $54.83M | $266.97M | (m) | $26.73M | $21.09M | $9.23M | (m) | 8.27× |
| 2020-03-31 | $231.39M | $51.08M | $53.61M | (m) | $28.89M | $27.70M | $12.94M | (m) | 4.53× |
| 2019-12-31 | $262.88M | $57.70M | $62.43M | (m) | $38.42M | $42.58M | $5.78M | (m) | 4.56× |
| 2019-09-30 | $209.29M | $33.10M | $39.53M | (m) | $24.34M | $12.80M | $3.50M | (m) | 6.32× |
| 2019-06-30 | $201.20M | $31.00M | $39.99M | (m) | $22.04M | $14.04M | $5.05M | (m) | 6.49× |
| 2019-03-31 | $183.74M | $27.35M | $33.68M | (m) | $20.62M | $13.43M | $5.67M | (m) | 6.72× |
| 2018-12-31 | $176.57M | $30.36M | $29.82M | (m) | $18.67M | $13.28M | $6.29M | (m) | 5.81× |
| 2018-09-30 | $175.25M | $24.77M | (m) | (m) | $19.66M | $13.54M | $5.59M | (m) | 7.07× |
| 2018-06-30 | $155.38M | $20.37M | (m) | (m) | $17.09M | $13.81M | $3.61M | (m) | 7.63× |
| 2018-03-31 | $147.37M | $18.65M | (m) | (m) | $17.55M | $12.78M | $4.84M | (m) | 7.90× |
| 2017-12-31 | $149.46M | $26.79M | $24.51M | (m) | $16.66M | $11.22M | $6.24M | (m) | 5.58× |
| 2017-09-30 | $137.22M | $19.81M | $19.32M | (m) | $16.95M | $8.97M | $3.56M | (m) | 6.93× |
| 2017-06-30 | $131.21M | $19.12M | $13.37M | (m) | $16.70M | $8.38M | $5.97M | (m) | 6.86× |
| 2017-03-31 | $123.74M | $14.64M | $8.62M | (m) | $14.43M | $7.49M | $3.93M | (m) | 8.45× |
| 2016-12-31 | $120.02M | $16.94M | $6.49M | (m) | $14.30M | $6.84M | $2.97M | (m) | 7.09× |
| 2016-09-30 | $114.59M | $18.84M | $4.99M | (m) | $11.75M | $6.45M | $4.71M | $3.04M | 6.08× |
| 2016-06-30 | $112.56M | $18.73M | $12.34M | (m) | $11.62M | $5.51M | $4.61M | $5.29M | 6.01× |
| 2016-03-31 | $104.60M | $17.99M | $10.39M | (m) | $9.57M | $5.06M | $3.58M | $7.50M | 5.81× |
| 2015-12-31 | $104.14M | $20.36M | $21.57M | (m) | $7.55M | $4.10M | $3.63M | $8.93M | 5.11× |
| 2015-09-30 | $104.83M | $19.68M | $93.34M | (m) | $6.98M | $3.15M | $4.10M | $8.82M | 5.33× |
| 2015-06-30 | $114.33M | $21.46M | $104.14M | (m) | $6.50M | $2.91M | $5.26M | $9.29M | 5.33× |
| 2014-12-31 | $10.55M | $20.19M | $2.30M | (m) | $5.40M | $2.26M | $3.30M | $8.53M | 0.52× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |